ST Elevation Myocardial Infarction Clinical Trial
Official title:
Procedure and In-hospital Outcome of Patients Under 40 Years Old Undergoing Primary Percutaneous Coronary Intervention for Acute ST Elevated Myocardial Infarction in Assiut University
Sample size of 117 patients presented with ST elevated myocardial infarction for PPCI starting from september 2017 will be divided to 2 groups, group 1 age up to 40 years old and group 2 older than 40 years then previous history and clinical data and angiographic data at PPCI and follow up in-hospital and after discharge for 3 months all these data will be compared at both groups.
Myocardial infarction (MI) is a disease of middle and advanced age.
Most of the present knowledge of infarction is derived from studies in this older cohort of
patients.
In fact, some clinical studies of patients with chest pain have excluded individuals under 40
years of age
Although thrombolytic therapy has been shown to improve survival in elderly AMI patients when
compared with placebo, many studies have shown lower mortality rates when these patients are
treated with primary percutaneous coronary intervention(PPCI) for AMI
Young adults are a relatively small portion of those having acute myocardial infarction
(AMI). However they are an important group to examine with regard to risk factor modification
and secondary prevention.
Previous studies have estimated that young patients of less than 40 years old make up between
2% and 6% of all AMI
young patients has different characteristics from that in the older coronary arteriography
performed in young patients after myocardial infarction has identified a relatively high
prevalence of angiographically normal coronary arteries.
Risk factor analysis in young AMI patients has revealed a high prevalence of current smoking,
hyperlipidemia and positive family history
In addition, non-classical risk factors such as vasospastic tendencies, thrombophilic
conditions and a history of Kawasaki disease have also been proposed as the causes of AMI in
young patients.
PPCI is now widely accepted as a therapeutic strategy for older patients with AMI. Early,
complete revascularization can salvage myocardium at risk and improve survival rates.
However on the basis of the difference in etiology of AMI, there is a possibility that the
clinical effectiveness of PCI for young adults with AMI might be different from that old
patients
Nevertheless, coronary artery disease has been recognized in young age groups more frequently
in recent years.
It is a topic of increasing clinical interest due to the potential for premature death and
long-term disability.
Aim of the study :
The purpose of the present study is to examine the clinical background, angiographic
findings, acute results and in-hospital outcome of PPCI in young adults with AMI (less than
40 years) compared with those non young group (more than 40 years) .
Type of the study: case only , prospective study .Study Setting: cardiology department ,
assuit university hospital , assuit , Egypt
Study subjects:
1. Inclusion criteria:
All patients with acute myocardial infarction (STEMI) : chest pain > 30 minutes and ST
segment elevation in more than one lead , treated with PPCI at assuit university
hospital starting from September 2017 .
2. Exclusion criteria:
Patients undergoing elective percutaneous intervention and thrombolytic therapy.
3. Sample Size Calculation: : Sample size was calculated using Epi-info version 3 , based
on previous studies , prevalence of MI in Egypt is 8.3 % , with confident level of 95 %
, the sample needed for the study was estimated to be about 117
Study tools (in detail, e.g., lab methods, instruments, steps, chemicals, …):
All patient will be subjected to :
1-history taking , clinical examination & assessment of clinical risk factors of coronary
heart disease as ( age , sex , family history ,DM , HTN ,smoking , addiction and type of
addiction , previous ACS ,previous PCI , psychic trauma ,history of chest obstructive , renal
and vascular disease , weight ,length ,BMI ,BSA , obesity , KILLIP class , ischemic time ,
preinfarction angina ,mode of transport 2-12 lead ECG before and after PPCI. 3-Angiongraphic
findings, acute results of PPCI ( previous PCI , culprit artery , if MVD , which segment
affected ,presence or absence of visible thrombus ,type of penetrating wire ,direct stenting
or not ,type of the stent , name of the stent , number of stents , diameter and length of
each stent , usage of thrombus aspiration , balloon dilatation ,diameter and length of the
balloon ,and inflation pressure ,volume of contrast ,final TIMI flow ,presence of
collaterals.
4-evaluation of PCI success (in-hospital):
a-angiographic success :( residual stenosis ≤ 30% and TIMI flow grade 3) and side branch
angiographic success (residual stenosis ≤ 50% and TIMI flow grade 3)
a- procedural success : achievement of angiographic success without major clinical
complication as ( death ,MI ,emergency coronary artery bypass surgery ) during
hospitalization .
c- clinical success : in the short term , recovering of signs and symptoms of myocardial
ischemia .
5-Therapuetic data as ( aspirin loading dose , clopidogrel loading dose ,maintenance dose and
its duration , ticagrelor loading dose ,maintenance dose and its duration , usage of
tirofiban intracoronary or intravenous ) 6- echocardiographic finding during admission ( EF
by Simpson and M-mode , SWMA, mechanical complication ) 7-laboratory finding during admission
( total cholesterol , LDL , HDL , TG , basal creatinine , creatinine at discharge ,basal CK
and CKMB , peak CK and CKMB , CK - CKMB - TNL at discharge , hemoglobin and platelet level )
8-follow up after 3 months for ( mortality , ACS, MI , target artery revascularization ,ISR
,HF ,follow up echo EF by Simpson and M-mode , SWMA )
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05601999 -
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
|
Phase 3 | |
Recruiting |
NCT06147986 -
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
|
Phase 2 | |
Not yet recruiting |
NCT05881382 -
Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction
|
Phase 3 | |
Enrolling by invitation |
NCT02615015 -
SNPs in the DNase 1 Gene Impair Its Activity and Are Increased in a STE-ACS Patient Cohort Compared to Healthy Controls
|
N/A | |
Recruiting |
NCT05812963 -
IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute STEMI
|
N/A | |
Recruiting |
NCT05554588 -
Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI
|
N/A | |
Recruiting |
NCT05450757 -
Shanghai ST-segment Elevation Myocardial Infarction Cohort
|
||
Active, not recruiting |
NCT03278509 -
Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
|
Phase 4 | |
Not yet recruiting |
NCT03263468 -
Revascularization StrategIes for ST Elevation Myocardial Infarction Trial
|
N/A | |
Completed |
NCT03156699 -
The Incidence, Effect and Persistence of Fragmented-QRS, in Patients Presenting With ST-Elevation Myocardial Infarction
|
||
Enrolling by invitation |
NCT04970238 -
Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction
|
Phase 4 | |
Recruiting |
NCT02557217 -
NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction
|
Phase 2 | |
Recruiting |
NCT02224534 -
Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
|
Phase 4 | |
Completed |
NCT01136187 -
Trial Comparing Radial and Femoral Approach in Primary Percutaneous Coronary Intervention (PCI)
|
N/A | |
Not yet recruiting |
NCT04068116 -
Impact of Ischemic Post-conditioning
|
N/A | |
Not yet recruiting |
NCT04063345 -
Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03646357 -
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
|
Phase 4 | |
Completed |
NCT03984071 -
The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI
|
||
Completed |
NCT03740776 -
The Eosinophils Percentage Predicts In-hospital Major Adverse Cardiac Events in STEMI Patients After PCI
|
||
Completed |
NCT03435133 -
Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI
|
N/A |